Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 20/01/2010
PIL Pepcid 20 and 40 mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/01/2010 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 01/07/2008 and displayed until 20/01/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 09/05/2008 and displayed until 01/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 08/01/2004 and displayed until 09/05/2008
Reasons for adding or updating:
  • Update to PIL
Updated on 18/08/2003 and displayed until 08/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 05/11/2001 and displayed until 18/08/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 05/11/2001 and displayed until 05/11/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 30/07/2001 and displayed until 05/11/2001
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   famotidine